Treating Obesity- NOT Just with Surgery

Similar documents
WEIGHT LOSS/MANAGEMENT IS IT JUST ANOTHER PIPE DREAM?

WHAT S THE SKINNY ON WEIGHT LOSS MEDICATION SAFETY? January 25, 2019 Pennsylvania Pharmacists Association

An Individualized Approach to Optimize Obesity Treatment Louis Aronne, MD

Realistic Expectations: Drugs in the Treatment of Obesity. Lora Cotton, D.O. January 20, 2013

WILSON HEALTH WEIGHT AND WELLNESS HEALTH HISTORY FORM

Understanding Obesity: The Causes, Effects, and Treatment Options

What Are the Effects of Weight Management Pharmacotherapy on Lipid Metabolism and Lipid Levels?

Putting It in Perspective Using Medications for Chronic Weight Management. Donna H. Ryan, MD Pennington Biomedical Research Center

Overweight and Obesity on the Menu. Marwan Akel, Pharm. D, MPH Clinical Assistant Professor School of Pharmacy Lebanese International University

Update on Treating Obesity: A Multidisciplinary Approach. Marie Harkins, FNP BC, CDE Cayuga Center for Healthy Living

Obesity Pharmacotherapy: Options and Applications in Clinical Practice. Scott Kahan, MD, MPH

Surgical History Please list all operations and dates:

Losing weight (and keeping it off) calls for changes to how you live your life, as well as to your connection to food and exercise.

Viriato Fiallo, MD Ursula McMillian, MD

Obesity: Pharmacologic and Surgical Management

What is obesity? OBESITY. Obesity is a health issue in which someone has so much extra fat that it negatively impacts their health.

Management of Obesity. Objectives. Background Impact and scope of Obesity. Control of Energy Homeostasis Methods of treatment Medications.

When Diet and Exercise Aren t Enough: Pharmacologic Management of Obesity

Learning Objectives. Currently Available Options. Update on Weight Loss Pharmacotherapy. Dan Bessesen, MD

MEDICAL MANAGEMENT 101

Disclosures. Objectives. Impact of Obesity in Primary Care Practice and What To Do About It. Intuitive Surgical. Consultant

2. Is the request for Alli, Xenical or Belviq? Y N. 3. Has the patient received 6 months or more of therapy? Y N

APhA March 2016 Annual Meeting Obesity Cases

Managing Obesity as a Disease. Disclosure. Objectives

Diabesity. Metabolic dysfunction that ranges from mild blood glucose imbalance to full fledged Type 2 DM Signs

Faculty Disclosures. Vera Tarman, MD, Author:

Without Background for printing as Pocket Reference

Anti-Obesity Agents Drug Class Prior Authorization Protocol

Navigating the new weight loss medications Jacqueline Jordan Spiegel, MS, PA-C, DFAAPA Associate Professor Midwestern University

I. ALL CLAIMS: HEALTH CARE PROFESSIONALS

The US FDA, EMA and our TGA use these cutpoints in assessing drug efficacy. Disclosures: Professor John B Dixon

Update on the Recent Advances in Obesity Management. Benjamin O Donnell, MD Oct 5 th, 2018

Obesity D R. A I S H A H A L I E K H Z A I M Y

Obesity Management in Type 2 Diabetes

Obesity: The Role of Pharmacotherapy The Annual Women s & Children s Health Update Saturday 17th February 2018 Benefits of modest weight loss 3-10%

Last Name: First Name: Address: Apt/Unit #: City: State: Zip: Best Contact Phone Number: Date of Birth: Age: Profession:

The New Trend of Anti-Obesity Drug

The ABCDs of Obesity

Medical Management of Obesity: Multidisciplinary Team and Pharmacologic Therapy. Shelby Sullivan University of Colorado School Of Medicine

Treatment of Obesity SAJIDA AHAD MERCY GENERAL SURGERY

Insurance Questions for Medical Weight Loss

Faculty/Presenter Disclosure

Americas Deadly Disease. Myths of how obesity came to be Eating food high in fructose, syrup, or a virus An epidemic disease

Chapter 10 Lecture. Health: The Basics Tenth Edition. Reaching and Maintaining a Healthy Weight

Copyright 2017 by Sea Courses Inc.

OBESITY-the Good, the Fat, and the Ugly

Coach on Call. Thank you for your interest in Lifestyle Changes as a Treatment Option. I hope you find this tip sheet helpful.

Part 1: Obesity. Dietary recommendations in Obesity, Hypertension, Hyperlipidemia, and Diabetes 10/15/2018. Objectives.

Patient Packet. SSM Health Dean Medical Group Weight Management Services 1313 Fish Hatchery Road Madison, WI 53715

Using New Guidelines to Improve Best Practices in Obesity Management

UnitedHealthcare Pharmacy Clinical Pharmacy Programs

OBESITY IN TYPE 2 DIABETES

TO PHARMACIST: PLEASE PROVIDE THIS INFORMATION TO THE PATIENT. Important Patient Information. Patient Information about XENICAL (orlistat) Capsules

Healthy weight 18.5 to <25. Diabetes Dispatch. Overweight 25 to <30. Obese class I 30 to <35. Obese class II 35 to <40

Where are We Now? Editor s Note: Who Qualifi es for Obesity Medications?

Identification, Evaluation, and Treatment of Overweight and Obesity in Adults Clinical Practice Guideline MedStar Health

PATIENT INFORMATION SHEET (please print) Patient s Name: Birthdate Age. Address: Soc.Sec.# Employer: Address: Phone: Spouse Name: Occupation:

Cravings are one of the main reasons diets fail

Understanding. Obesity. An educational resource provided by the Obesity Action Coalition

9 out of 10 people struggle with food cravings while dieting?

9 out of 10 people struggle with food cravings while dieting?

Dietary recommendations in Obesity, Hypertension, Hyperlipidemia, and Diabetes. Stephen D. Sisson MD

Some Issues in the Management of Hypothyroidism

ITG Diet Health Status Intake Form

FDA approves Belviq to treat some overweight or obese adults

Initial Client Questionnaire

Chapter 9 Weight Control: Overweight and Underweight

Overview of Management of Obesity

Learning Objectives 11/8/2014. Obesity: Strategies to Tackle the Epidemic MA ACP Annual Scientific Meeting 1. Body Mass Index Calculation

Identification, Evaluation, and Treatment of Overweight and Obesity in Adults

An Introduction to Bariatric Surgery

Featured Topic: Weight Loss Fiber, Grape Seed Extract, and Ginger (6 slides)

First Name. Profession. Weight lbs. Weight 1 year ago lbs. Min. Adult Weight lbs. at age Maximum Weight lbs. at age

INTERMITTENT FASTING PROTOCOL

Now is the time for a trimmer, healthier you.

Past, Present and Future of Pharmacotherapy for Obesity

Patient Information Date: / /

Metabolic Syndrome. Shon Meek MD, PhD Mayo Clinic Florida Endocrinology

Denise E. Bruner, M.D. & Associates, P.C.

PHENTERMINE INFORMATION SHEET

HEALTH TRANSITIONS CLINC: PART 1: Weight, Diet and Exercise History

Lecture 18: Weight Management. Celebrity Role Models? Celebrity Role Models? Nutrition 150 Shallin Busch, Ph.D.

Obesity. Picture on. This is the era of the expanding waistline.

Statement of Objectives:

Weight: lbs. Weight 1 year ago: lbs. Min. Adult Weight: lbs at age

The Diennet Institute

Application of the Diabetes Algorithm to a Patient

Preoperative Tests & Consults

Integrative Consult Patient Background Form

Welcome to our Center! We are so glad you have chosen our center to assist you with your weight loss goals!

Evolve180 / Ideal Northwest Health Profile

Non-surgical Treatment for Adult Obesity

BARIATRIC PROGRAM PATIENT HEALTH HISTORY QUESTIONNAIRE (PLEASE PRINT CLEARLY)

Meridian Clinic. Medical Weight Loss Program Guide Booklet. It s time to meet the new you

Rachael Hunt KNH 413 Diet Instruction Weight Reduction. Patient: Patient: G.M Age: 36 Sex: female Weight: 183 Ht: 5 3 Occupation: receptionist

WEIGHT LOSS NEW PATIENT INTAKE

New Patient Health Information

Patient Care. How We Approach Pre-op Documentation and Post-op Follow Up

DOCTOR PRESCRIBED DIET PILLS PHENTERMINE 375 MG

Weight: lbs. Weight 1 year ago: lbs. Min. Adult Weight: lbs at age

Transcription:

Treating Obesity- NOT Just with Surgery Identify obesity as a major health problem Define and describe causes of obesity with contributing factors. Discuss pertinent details to seeing an obese patient in an office. Discuss the prominent proven effective weight loss drugs on the market today and when and how to utilize them. Present case studies demonstrating the use of these drugs. Obesity- over ideal weight by 30% or BMI over 30 Morbid Obesity- Clinically severe obesitypoint where serious medical conditions occur as a direct result of the obesity Defined as >200% of ideal weight, >100 lb overweight, or a body mass index of ³40 1

BMI = Formula: weight (lb) / [height (in)]2 x 703 Calculate BMI by dividing weight in pounds (lbs) by height in inches (in) squared and multiplying by a conversion factor of 703. Example: Weight = 150 lbs, Height = 5 5 (65") Calculation: [150 (65)2] x 703 = 24.96 W.H.O. Classification BMI Ideal Weight 20 24.9 Overweight 25 29.9 Moderate Obesity 30 34.9 Severe Obesity 35 39.9 Morbid Obesity 40 49.9 Super Obesity 50+++ (Men Waist 40 inches Women Waist 35 inches) More adverse health effects with increased fat inside the abdominal cavity. 1.9 billion World wide overweight 600 million World wide obese 97 million in the US obese which represents 36.5% of the US population and 32.3% overweight (No US state with less than 20%) 20.6% of kids age 12-19 in US are obese 6.3% in US are in the extreme obese range 4 out of 5 African American Females in US Medical Cost is $147 billion/year ($1429 more than the normal person) 2 nd Leading cause of preventable deaths Slightly underweight insects, fish, reptiles, birds, mammals and people live longer than the overweight. Study University of Cambridge-July, 2016 Mortality risk increase: 7% increase if BMI 25-27.5 20% - BMI 27.5-30 45% - BMI 30-35 94% - BMI 35-40 3 fold increase if BMI over 40 **Deaths due to CV, Respiratory or Cancer (in order) 2

To lengthen thy life, lessen thy meals. Benjamin Franklin Obesity is a disease!!!! Declared by the AMA in 2014. Complex entity with many causes: Endocrine(hypothyroid, hyperfunctioning adrenal gland) Too many calories burn off hypothalamic neurons which results in damage to neural pathways that reg. food intake and body fat mass Genetics Hormonal (PCOS, post menopausal) or Insulin resist. Depression, Stress, Lack of Sleep, Drugs-Lyrica, SSRI s (Paxil), Sulfonyreas, Steroids, Beta Blockers Leptin falls, Ghrelin raises, GLP1 and PYY goes down Eating out/ordering in & foods not healthy Portion sizes increased (soda 6 ½ oz to 20oz) Consumption of soft drinks (600 12 oz/pp/per year, males 12y-29y=1/2 gal/d or 160 gal/yr) Rushed meals Junk food is advertised, cheap and available No time to exercise Technology especially for children Unrealistic expectations 3

Diabetes 15-30% Hypertension 20-55% Hyperlipidemia 35-53% Cardiac disease 10-20% Respiratory disease 15-20% Sleep apnea Syndrome 50-65% Arthritis 70-90% Depression 50-65% Stress Incontinence 30-45% Menstrual irregularity 50-65% Metabolic Syndrome 40% >age 60 (Cancers, gallbladder disease, migraines, gout, PCOS-over 100 diseases identified) Cannot be about dieting!!!! Only 5% of the people that diet can maintain their weight loss. They do not work!! (10% wgt loss=dec/ It cannot be about counting calories!!!! Not all calories are the same or when you eat them. It cannot be about depravation!!! It must be about portion control and things in moderation. Do not overwhelm your patient. Set small realistic goals. (4-8 lbs a month or 5-10% 6 m.) Thorough H&P -include pertinent items like history of renal calculi, migraines, glaucoma, depression, what they are using for birth control, etc to help guide your choices of medicines later. Includes a 24 hour food recall. Obtain baseline labs-cbc, CMP, Lipids, T3,T4, TSH, PTH, Vit D3, Vit B12, Insulin, Iron, Ferritin, TIBC, HgbA1C Assess their emotional needs as well (schedule enough time for these patients). Be sure to have larger gowns, blood pressure cuffs, and make sure your chairs in the waiting room, exam table, and scales can accommodate a larger person. Toilets floor mounted Take height, weight, BMI, and waist measurements. Empathy important with good listening skills. Support and encouragement essential-make sure the patient understands they have a disease that needs to be treated. Set mini goals and always follow up (make an appointment before they leave the office). See them monthly initially. Evaluate triggers like stressors or current meds that may cause weight gain-ssri s (Paxil), Tricyclic Antidepressants, Abilify, Insulins, sulfonylureas, steroids, Lyrica, & beta blockers Offer the appropriate medication(s) like Wellbutrin, Phentermine, Topamax,, or Qysemia, Contrave, Belvig, Saxenda. 4

Offer individual or group support if needed Be motivational to patient and explain that this is a disease Encourage the patient to buy clothes that fit as they are losing Encourage the pt to take pictures before and as they are losing weight Set 2-3 goals each visit and review them each visit See them monthly until they are stable then every couple of months Generic Name Trade Names DEA Schedule Approved Use Year Approved Phentermine/ Topiramate ER Naltrexone ER/Bupropion ER Qsymia IV Long-term 2012 Contrave None Long-term 2014 Liraglutide Saxenda None Long-term 2014 Phentermine Adipex, IV Short-term 1973 Orlistat Xenical None Long-term 1999 Larcaserin Belviq or Belviq ER IV Long-term 2012 Generic Name Trade Names Dose Mechanism of Action Side Effects/ Precautions Phentermine/ Topiramate ER Qsymia 3.75 mg/23 mg daily x 14 days then 75mg/46mg a day Sympathomi metic/antiepil eptic Suppresses appetite Dry mouth, anxious, feeling off, numbness, insomnia, ^BP Do not use glaucoma, preg. (fetal toxicity)br. feeding Hyperthyroid Naltrexone ER/Bupropion ER Contrave 8mg/90mg Start 1 q day week 1 then week 4 should be 2 am 2 pm Opioid Antagonist/ antiepileptic Regulates appetite and reward system Headache, dry mouth, diarrhea, ^ BP and dizziness Do not use with opioids, preg./breast feeding, seizures 5

Phentermine Adipex-P Lamaira 8mg, Usually start 15mg q day can be BID Suppresses appetite Dry mouth, anxious, insomnia, ^BP Do not use glaucoma, preg. br. feeding Hyperthyroid Severe anxiety Orlistat Xenical 120 mg tid before meals GI lipase inhibitor- Promotes fat excretion ^gas, bowel movements& incont. Of stool. Do not use in malabsorption Larcaserin Belviq or Belviq ER 10mg BID or 20mg ER q day Appetite suppressant HA, constipation, fatigue, Caution with use with SSRI-serotonin syndrome Saxenda and Qsymia decreased progression by 80-79% and all the other meds were between 36-37% decrease. Other Benefits: Decrease triglycerides, increase HDL Reverse fatty liver Decrease SUI and increase sexual function Decrease DOE and hypoxia Decrease CV events and mortality Increase over all quality of life In order of best to least: ú Qsymia ú Saxenda ú Contrave ú Belviq ú Orlistat ú Discontinue rate for any of the meds were 2.8% with Saxenda being the highest due to GI side effects. ú None can be used in pregnancy or breast feeding. ú All can be used in mild to mod. CRF or mild liver disease. Garvey WT, et al. Endocrine Practice, 2016 315:842-884 Khera R, et al. JAMA 2016 315: 2424-2434 and Drugs at FDA approved drugs products 6

61 y/o Jenny Smith presents to your office wanting to lose weight. She has tried on her own and loses 10-15 lbs but then gains it back. She has a history of COPD, HTN that is not controlled on Amlodipine 10mg a day and Lisinopril 10mg a day. Her height is 65 in. weight 234 and she refuses to let you measure her waist. Her BMI is 38.44. VS 132/86-78-20 pulse ox 94% She is on Medicare. What category of obesity is she in? What other things do you want to know? You continue to assess Jenny and find out she does not have a history of glaucoma or kidney stones. She does state that she is depressed over her situation because she lives with her mom and she knows her smoking caused her COPD. She cannot exercise so she put on the weight. She says she does not over eat but her choices are poor and she craves sweets. She drinks at least 2 ginger ale s a day. You have the opportunity to review the labs from the PCP who referred her and other than a slightly elevated cholesterol they are within normal. Based on the information that you have, what medicine would you chose for Lisa? What goals would you set? 7

Jenny returns in a month and states she is feeling somewhat better but still having some cravings. Was able to meet the goal of sweets 2 of the weeks but had difficulty the other 2 weeks but did eat less sweets even in those weeks. She changed her ginger ale s to diet ginger ale s. Her weight was 228 (232 prev.) Vs 128/84-76-24, pulse ox 95% What changes would you make at this time? What goal might you add? 48 y/o male with history of gastric sleeve 3 years ago and had done very well with losing over 90 lbs but now has gained back about half of the weight. States he can eat more and is hungry most of the time but is skipping breakfast. He also c/o feeling tired. He is not exercising. Hgt 6ft 1 in, 235 lbs, BMI 31. He is seeking help before he gains all of his weight back. He has no history except HTN on Lisinopril 20mg. His vs are 154/96-94-24, pulse ox 96%, waist 39.5 in. You obtain the labs: CBC, CMP, Lipids, TSH, free T3, B12, D3, PTH, HgbA1C, Insulin, Copper, Zinc. What obesity category is John in? Would you start John on any medicine? What goals would you set for John? John s labs came back and all were normal except the following: Insulin level 132 B12 134 D3 27 HgbA1C 6.1 Would you add any medicine to John s regimen based on these labs? How much weight would you expect for John to lose the next visit? 8

John returns 4 weeks later and states doing well with meds. Had some numbness first week but that went away. Now having some dizziness when bending over and tying his shoes. Denies heart palpitations, trouble sleeping or constipation. States he met all of his goals. VS- 102/58-78-18 pulse ox 98% wgt. 226 (from 242) What is your next step? Obesity is a chronic disease Modest weight loss (5% -10% of body weight) can have considerable medical benefits Pharmacotherapy should be offered to patients as a medication for their disease just as you would offer for a patient with HTN or diabetes. Be your patients health care provider, advocate, motivator and cheerleader!! 9

. 10